CLDX | NASDAQ Stock Exchange

Celldex Therapeutics
+ Share

Ulcer Index /
Celldex Therapeutics: Ulcer Index 15.068 [High Stress]

[BULLISH]: Celldex Therapeutics UIX index implies that the downside risk of the current trading price is high. Currently, the UIX is 15.068.

Camarilla Pivot Points /
Celldex Therapeutics has moved above the R2 Camarilla pivot point ($6.803) [Bullish]

Celldex Therapeutics has broken the first Camarilla resistance point ($6.803) [Bullish]. Look for a long limit order entry near this point. Exit price for CLDX should be set @$6.803 & Stoploss for Celldex Therapeutics should be set between $4.917 & $4.445

Percentage Volume /
Percentage volume oscillator is now negative for CLDX

[BEARISH CROSSOVER]: Celldex Therapeutics currently has negative PVO -3.95%. The recent volume is losing momentum through a fall on the short term exponential moving average. Currently, the return on PVO is 0%.

Coles Reaction Day /
CLDX: Short term trend has confirmed a rally day

CLDX: CRD Current Signal -> (1) 15 Feb: BULLISH (2) 14 Feb: NEUTRAL (3) 13 Feb: BULLISH

Woodie Pivot Point /
Limit order for a long position has been identified for Celldex Therapeutics [Bullish]

Celldex Therapeutics has broken the first Woodie resistance point ($6.55) [Bullish]. Look for a long limit order entry near this point. Exit price for CLDX should be set @$6.55 & Stoploss for Celldex Therapeutics should be set at $4.87

Commodity Channel Index /
Price extreme for CCI confirms signal reversal for Celldex Therapeutics

[BEARISH]: Celldex Therapeutics (NASDAQ:CLDX) current trading has maintained the Commodity Channel Index to overbought status and signalled the continuation of the bearish trading conditions. Currently, the CCI is 147. The bearish signal has been active for 0 day. During the quarter, the highest CCI value was 661.

Top companies for
NASDAQ Stock Exchange
See Trending
Company
Volume Rate of Change /
Celldex Therapeutics currently has negative volume rate of change for -39

[BEARISH]: Celldex Therapeutics currently has negative rate of change of -39%. This means the current volume is less than the price 14 days ago and therefore losing momentum. Currently, the return on momentum is 13.3%.

Simple Moving Average /
[Bullish]: SMA(15) is serving as a support line for Celldex Therapeutics

CLDX: SMA Recent Trading -> (1) 15 Feb: 2.0821 (2) 14 Feb: 1.7148 (3) 13 Feb: 1.391

Open Tod Vs Close Tod /
Open/close reversal: Buyers were in control of trading all day for CLDX

[BULLISH STRONG]: Celldex Therapeutics opened in the lower part of daily range at 2.4% & closed in the upper part of the trading range at 85.7%. This suggests the buyers were in control all day. Over the last 12 months there has been 1 trading days with the opening price in the lower shadow & the closing the price in the upper shadow giving a confirmation ratio of 0.4%. Over the last month there has been 1 trading days with the opening price in the lower price range & the closing the price in the upper price range giving a confirmation ratio of 9.1%.

Ease of Movement /
Celldex Therapeutics was easily moved upward on low volume in recent trading [Bullish]

CLDX: EOM Current Signal -> (1) 15 Feb: BULLISH EASY (2) 14 Feb: BEARISH HARD (3) 13 Feb: BULLISH EASY

Close Tod Vs Range Tod /
Celldex Therapeutics: Buyers are in control at the market close.

[BULLISH]: Celldex Therapeutics buyers are in control at the market close. This is the first day of buyer commitment for Celldex Therapeutics adding strength to an uptrend in the first timeframe & highlights the commitment of buyers to carry positions overnight. Over the last 12 months there has been 3 trading days with the closing price in the upper part of the range giving a confirmation ratio of 1.1%. Over the last month there has been 3 trading days with the closing price in the upper range giving a confirmation ratio of 27.3%. Currently this quarter, closing price has spent 3 days in the upper price range compared to 2 days in the lower range giving a ratio of 1.5x.

Chaikin Money Flow /
Celldex Therapeutics continues positive divergence & potential shift in direction

[BULLISH]: Celldex Therapeutics current price has highlighted recent buying pressure and the continuation of a bullish trading conditions. Currently, the CMF is 0.04. Celldex Therapeutics (NASDAQ:CLDX) received a confirmed CMF crossover days on the Jan 29 2019. The bullish signal has been active for 1 day. During the quarter, the highest CMF value was 0.21 occurring on the Jan 29 2019.

Williams %R /
Overbought signal for the William %R is still current for Celldex Therapeutics

[BULLISH]: Celldex Therapeutics is currently Oversold highlighting the potential for a short term trend reversal in the upward direction.

Daily Volume Index /
Celldex Therapeutics is being actively distributed based on DVI

[BEARISH]: Celldex Therapeutics (NASDAQ:CLDX) current distribution has given weakness to the share price and the continuation of bearish trading conditions. Currently, the DVI is -29111.

Elder Ray Index /
Bull power has increased for Celldex Therapeutics signalling bullish conditions are likely

[BULLISH]: Celldex Therapeutics Elder Ray Index is signalling a Bullish movementERI is 2.753 indicating bull power. Prices are being driven above the consensus of value for CLDX during the last trading session [Buying Pressure]

Moving Average Envelope /
Envelope bands Overbought signal is still current for Celldex Therapeutics [Bullish]

CLDX: Envelope Bands Current Signal -> (1) 15 Feb: BULLISH (2) 14 Feb: BULLISH (3) 13 Feb: BULLISH

Bill Williams Market Facilitation /
Market movement acceleration likely for CLDX as a result of Green Day

Celldex Therapeutics Currently is a confirmed Green Day. Both MFI & volume are down for CLDX. Trend continuation likely for CLDX from increased trading activity.

Close Tod Vs Close Yest /
This quarter, the largest upswing rally has been 5 days giving a total rally upward movement of 1129.9%

CLDX: Recent Performance ->(1) 15 Feb: 13.3% (2) 14 Feb: -6.5% (3) 13 Feb: 10.8%

MACD Volume /
Volume MACD oscillator remains negative for CLDX

[BEARISH]: Celldex Therapeutics currently has negative Volume MACD of -1.7421e+006. This means the signal line is less than the Volume MACD line signalling a bearish movement.

Average Directional Movement /
Daily trading has confirmed an ADX very strong trend (62.24) for Celldex Therapeutics

[Stong Trend]: ADX for CLDX has confirmed a very strong trend is present. Celldex Therapeutics has an ATR(14) of 0.551, a DX of 87.03 & an ADX(14) of 62.24

Percentage Price /
Price percentage oscillator has positive momentum signalling a continuation of the upward price rise for CLDX

CLDX: PPO Current Signal -> (1) 15 Feb: BULLISH (2) 14 Feb: BULLISH (3) 13 Feb: BULLISH

Sine Weighted Moving Average /
[Uptrend]: Recent trading for CLDX indicates ST trend is likely to continue

CLDX: SWMA Recent Trading -> (1) 15 Feb: 1.733 (2) 14 Feb: 1.331 (3) 13 Feb: 0.997

MACD /
Celldex Therapeutics: MACD (0.7409)

[BULLISH]: Celldex Therapeutics currently has positive MACD of 0.7409. This means the signal line is greater than the MACD line signalling a bullish movement.

Relative Strength Index /
Overbought signal for the Relative Strength Index is still current for Celldex Therapeutics [OVERBOUGHT]

[BEARISH]: Celldex Therapeutics is currently Overbought highlighting the potential for a short term trend reversal in the downward direction. RSI is currently overbought @89.2

Aroon Oscillator /
Daily trading has confirmed an Aroon strong uptrend (72) for Celldex Therapeutics

CLDX: Aroon Oscillator Current Signal -> (1) 15 Feb: BULLISH STRONG (2) 14 Feb: BULLISH STRONG (3) 13 Feb: BULLISH STRONG

Pivot Points /
Celldex Therapeutics has moved above the R2 pivot point ($6.5) [Bullish]

Celldex Therapeutics has broken the first resistance point ($6.5) [Bullish]. Look for a long limit order entry near this point. Exit price for CLDX should be set @$6.5 & Stoploss for Celldex Therapeutics should be set between $4.82 & $4.5

Exponential Moving Average /
The EMA trend following signal is still current for Celldex Therapeutics [Bullish]

[BULLISH]: Celldex Therapeutics currently has a confirmed uptrend. Recent trading has caused the EMA 15 day average to exceed the closing price confirming the short term trend following indicator. Currently, the return on EMA15 is 13.3%.

See More   See more results
back to top